Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasonographic changes in median nerve cross-sectional area in the elderly: effects of aging and type 2 diabetes.

BMC geriatrics·2025
Same author

Long COVID-19: a Four-Year prospective cohort study of risk factors, recovery, and quality of life.

BMC infectious diseases·2025
Same author

The incidence, clinical features and outcome of urinary tract infections in geriatric patients: A prospective longitudinal study.

IJID regions·2024
Same author

The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study.

Viruses·2023
Same author

Application of Mathematical Modeling in Prediction of COVID-19 Transmission Dynamics.

Arabian journal for science and engineering·2022
Same author

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents.

Hepatic medicine : evidence and research·2014

Related Experiment Video

Updated: Jul 8, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Acute hepatitis C: prospects and challenges.

Sanaa M Kamal

    World Journal of Gastroenterology
    |December 29, 2007
    PubMed
    Summary
    This summary is machine-generated.

    Early treatment of acute hepatitis C offers better outcomes. Prompt intervention leads to improved viral eradication and simpler, more affordable treatment options for hepatitis C patients.

    More Related Videos

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
    04:11

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

    Published on: December 15, 2023

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
    04:11

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

    Published on: December 15, 2023

    Area of Science:

    • Hepatology
    • Virology
    • Infectious Diseases

    Background:

    • Hepatitis C affects over 170 million globally, with acute cases often asymptomatic and undiagnosed.
    • Spontaneous resolution is possible in acute hepatitis C, creating a treatment paradox.
    • Chronic hepatitis C presents a worse prognosis, requiring intensive, lengthy, and less successful treatments.

    Discussion:

    • Rationale for treating acute hepatitis C includes preventing progression to chronic infection.
    • Early intervention improves viral eradication rates compared to later treatment.
    • Acute hepatitis C treatment can be less expensive, better tolerated, and shorter in duration.

    Key Insights:

    • Acute hepatitis C is frequently asymptomatic, leading to delayed diagnosis.
    • Prompt treatment of acute hepatitis C enhances viral clearance.
    • Early treatment regimens are more convenient and cost-effective.

    Outlook:

    • Further research into optimal early treatment strategies for acute hepatitis C is warranted.
    • Public health initiatives to improve early diagnosis of hepatitis C are crucial.
    • Developing more accessible and effective treatments for hepatitis C remains a priority.